Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Barrios

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Tree Physiology|June 1, 2018
Variations in xylem embolism susceptibility under drought between intact saplings of three walnut speciesThorsten Knipfer, Felipe H Barrios-Masias, Italo F Cuneo, et al.
British Journal of Cancer|May 23, 2013
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinomaR J Motzer, B Escudier, R Bukowski, et al.
Ecancermedicalscience|February 28, 2024
Current scenario and future perspectives of clinical research in Brazil: a national surveyHeloisa Resende, Taiane F Rebelatto, Gustavo Werutsky, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2013
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort studyPedro E R Liedke, Dianne M Finkelstein, Jackie Szymonifka, et al.
American Journal of Clinical Oncology|August 19, 2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinomaElena G Chiorean, Tomislav Dragovich, John Hamm, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2019
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1Filippo Montemurro, Paul Ellis, Antonio Anton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial<sup>☆</sup>F Montemurro, S Delaloge, C H Barrios, et al.
Public Health|June 4, 2017
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American regionJ Martínez-Mesa, G Werutsky, S Michiels, et al.
NPJ Breast Cancer|September 19, 2022
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancerCarlos H Barrios, Shigehira Saji, Nadia Harbeck, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2015
The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal TumoursCarlos H Barrios, Martin E Blackstein, Jean-Yves Blay, et al.
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Tree Physiology|June 1, 2018
Variations in xylem embolism susceptibility under drought between intact saplings of three walnut speciesThorsten Knipfer, Felipe H Barrios-Masias, Italo F Cuneo, et al.
British Journal of Cancer|May 23, 2013
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinomaR J Motzer, B Escudier, R Bukowski, et al.
Ecancermedicalscience|February 28, 2024
Current scenario and future perspectives of clinical research in Brazil: a national surveyHeloisa Resende, Taiane F Rebelatto, Gustavo Werutsky, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2013
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort studyPedro E R Liedke, Dianne M Finkelstein, Jackie Szymonifka, et al.
American Journal of Clinical Oncology|August 19, 2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinomaElena G Chiorean, Tomislav Dragovich, John Hamm, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2019
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1Filippo Montemurro, Paul Ellis, Antonio Anton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial<sup>☆</sup>F Montemurro, S Delaloge, C H Barrios, et al.
Public Health|June 4, 2017
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American regionJ Martínez-Mesa, G Werutsky, S Michiels, et al.
NPJ Breast Cancer|September 19, 2022
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancerCarlos H Barrios, Shigehira Saji, Nadia Harbeck, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2015
The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal TumoursCarlos H Barrios, Martin E Blackstein, Jean-Yves Blay, et al.
Pageof 19